Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hatton

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 9, 2010
Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)C Le Péchoux, A Laplanche, C Faivre-Finn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004
Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer GroupR M Rudd, N H Gower, S G Spiro, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 26, 2020
Predicting the Risk of Disease Recurrence and Death Following Curative-intent Radiotherapy for Non-small Cell Lung Cancer: The Development and Validation of Two Scoring Systems From a Large Multicentre UK CohortM Evison, E Barrett, A Cheng, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 17, 2021
Neutrophil-Lymphocyte Ratio and Absolute Lymphocyte Count as Prognostic Markers in Patients Treated with Curative-intent Radiotherapy for Non-small Cell Lung CancerA Punjabi, E Barrett, A Cheng, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 12, 2021
Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UKK Banfill, W Croxford, I Fornacon-Wood, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 28, 2023
Impact of the COVID-19 Pandemic on Outcomes for Patients with Lung Cancer Receiving Curative-intent Radiotherapy in the UKI Fornacon-Wood, K Banfill, S Ahmad, et al.
The British Journal of Surgery|March 24, 2021
Bridging the age gap in breast cancer: impact of omission of breast cancer surgery in older women with oestrogen receptor-positive early breast cancer on quality-of-life outcomesJ L Morgan, A Shrestha, M W R Reed, et al.
The British Journal of Surgery|March 24, 2021
Bridging the age gap in breast cancer: cluster randomized trial of two decision support interventions for older women with operable breast cancer on quality of life, survival, decision quality, and treatment choicesL Wyld, M W R Reed, K Collins, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 9, 2010
Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)C Le Péchoux, A Laplanche, C Faivre-Finn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004
Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer GroupR M Rudd, N H Gower, S G Spiro, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 26, 2020
Predicting the Risk of Disease Recurrence and Death Following Curative-intent Radiotherapy for Non-small Cell Lung Cancer: The Development and Validation of Two Scoring Systems From a Large Multicentre UK CohortM Evison, E Barrett, A Cheng, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 17, 2021
Neutrophil-Lymphocyte Ratio and Absolute Lymphocyte Count as Prognostic Markers in Patients Treated with Curative-intent Radiotherapy for Non-small Cell Lung CancerA Punjabi, E Barrett, A Cheng, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 12, 2021
Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UKK Banfill, W Croxford, I Fornacon-Wood, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 28, 2023
Impact of the COVID-19 Pandemic on Outcomes for Patients with Lung Cancer Receiving Curative-intent Radiotherapy in the UKI Fornacon-Wood, K Banfill, S Ahmad, et al.
The British Journal of Surgery|March 24, 2021
Bridging the age gap in breast cancer: impact of omission of breast cancer surgery in older women with oestrogen receptor-positive early breast cancer on quality-of-life outcomesJ L Morgan, A Shrestha, M W R Reed, et al.
The British Journal of Surgery|March 24, 2021
Bridging the age gap in breast cancer: cluster randomized trial of two decision support interventions for older women with operable breast cancer on quality of life, survival, decision quality, and treatment choicesL Wyld, M W R Reed, K Collins, et al.
Pageof 4